The IHD strain of vaccinia virus caused the rounding of all LLC-MK2 cells in a culture within 2 to 4 hr after infection. One #g./ml. of either cycloheximide or streptovitacin A protected 75 ~ of the infected ceils from early cytopathic effects occurring 4 hr after infection and treatment. As much as 83 #g./ml. of puromycin was required to achieve the same degree of inhibition. Puromycin (33 o/~g./ml.) continued to protect > 9o ~ of the infected cells 24 hr after infection, while < 4o ~ of cells treated with cycloheximide (3oo #g./ml.) or streptovitacin A (3oo/~g./ml.) were protected from virus cytopathic effects at 24 hr. Seventy-five per cent inhibition of virus reproduction was achieved with 24#g./ml. puromycin, oq25 #g.]ml. cycloheximide and 0.062/~g./ml. of streptovitacin A. When either puromycin (33o #g./ml.) or cycloheximide (3oo #g./ml.) was removed from infected cultures after a treatment period of 4 hr, cell rounding began shortly thereafter and was complete I hr later. However, after the removal of streptovitacin A (3oo #g./ml.) there was a ~ hr delay before virus cytopathic effects appeared. The cytopathic effects reached maximum 3 hr after the removal of the compound. When streptovitacin A was removed from LLC-MK 2 cells infected with vaccinia virus the yield was 3 ° ~ of control 24 hr after infection. Virus yields from L2 cells treated with streptovitacin A, however, were only I to 5 ~ of control yields. The aminonucleoside of puromycin (33o #g./ml.) markedly inhibited virus replication, but did not significantly alter the development of virus cytopathic effects.
INTRODUCTION
Increasing evidence indicates that virus cytopathic effects are related to virusinduced protein synthesis (Bablanian, Eggers, & Tamm, r965 b; Gauntt & Lockhart, I966; La Placa, 1966; Scholtissek, Becht & Drzeniek, 1967 ; Amako & Dales, 1967; Bubel, I967; Gauntt & Lockhart, I968) . Even the well-documented cytotoxic effect of vaccinia virus occurring in the absence of production of infectious virus (Bernkopf, Nishmi & Rosin, I959; Brown, Mayyasi & Officer, I959; Hanafusa, I96o; Tagaya, Kitamura & Sano, I963) was shown to be related to virus-induced protein synthesis (Bablanian, I968) .
In the present study two inhibitors of protein synthesis, cycloheximide and streptovitacin A, which have a mechanism of action distinct from that of puromycin, were tested to determine if their site of action was critical to the inhibition of the early virus cytopathic effects. Cycloheximide and streptovitacin A are thought to inhibit the incorporation of amino acids into protein by preventing the transfer of the activated amino acids from amino acyl soluble RNAs into protein (Siegel & Sisler, I963; Bennett, Ward & Brockman, I965) . Puromycin, however, causes the premature dissociation of the growing peptide chains (Allen & Schweet, I962 ) and alters the polysome pattern (Noll, Staehelin & Wettstein, I963) . In addition, studies were made with the aminonucleoside derivative of puromycin, which preferentially inhibits ribosomal RNA synthesis and not polypeptide polymerization (Nathans & Neidle, I963; Farnham, I965) , to provide additional evidence that polypeptide assembly is critical for the production of the cytopathic effects of vaccinia virus.
METHODS
Virus. The International Health Division strain (roD) of vaccinia virus, obtained from the American Type Culture collection, was used. Virus seeds were prepared in LLC-MK 2 cells, a continuous cell line of monkey kidneys or in L 2 cell monolayers, or on the chorioallantoic membrane (CAM) of I2-day-old chick embryos.
Celt lines andgrowth media. The LLC-MKz continuous monkey kidney cell line and the L2 cell line derived from a clone of Earle's L strain (Rothfels et al. I959) were used. Reinforced Eagle's medium supplemented with IO ~ foetal serum (Bablanian, Eggers & Tamm, I965a) Injection of cell cultures in the presence or absence of compounds. Cell cultures growing in 3o x IO ram. (Falcon) plastic dishes were infected at a virus to cell multiplicity of 5o:I. Concurrently, replicate cell cultures were infected and treated with compounds at varying concentrations as previously described (Bablanian, I968) .
Quantification of virus-induced cytopathological changes. The percentage of virusinduced morphological damage was determined as previously described (Bablanian, 1968) .
Measurement of virus yield. The yield of infective virus was determined by plaque assay in LLC-MK2 or L2 monolayer cultures (Bablanian, 1968 ) .
Antiserum. On the shaved backs of two rabbits, six spots, approximately 2o ram. in diameter, were gently sand-papered. One drop of undiluted vaccinia virus seed, prepared on the CAM of ~2-day old chick embryos, was placed on each spot and worked into the skin by a rotary motion. Three weeks later each rabbit was injected intravenously with z ml. of undiluted virus. The rabbits were bled ~5 days later and the serum separated from the clot.
Measurement of virus penetration in the presence of protein inhibitors. To study the absorption and penetration of vaccinia virus into LLC-MK2 cells in the presence of the protein inhibitors the following experiment was performed. Cells were infected with vaccinia virus in the presence of the compounds and adsorption was permitted for I hr at 37 ° in a humidified atmosphere of 5 ~o CO2 and 95 ~ air (Table 4) . After ad-sorption the supernatant fluids were collected (Group I) to measure the amount of unadsorbed virus. The infected or infected and treated cells were washed twice with 2 ml. of phosphate buffered saline and received 2 ml. medium or compound. After an additional hour's incubation at 37 ° the medium and compound were removed (Group II). The cells were then washed three times with 2 ml. of phosphate buffered saline and treated with z ml. of I : lo antiserum to neutralize unadsorbed virus and terminate further adsorption. Two hours later the antiserum was removed (Group III) and virus cytopathic effects were recorded. All supernatant solutions were stored at -2o °. The cells were then washed three times with 2 ml. phosphate buffered saline and covered with 2 ml. of reinforced Eagle's medium containing to %o foetal calf serum. These cultures were incubated for a further 2o hr and then both cells and medium were collected and treated for ~5 sec. at 8o ~0 of full power with an ultrasonic generator driving a' needle-probe' transducer (Brondwill Biosonik I1, no. BP-II-4o T) (Group IV). All groups (I to IV) were assayed for virus content as previously described.
Labelled precursor. L-leucine-4,5-3H, with a specific activity of 55"5 c/m-mole, was obtained from New England Nuclear Corporation, Boston, Massachusetts.
Procedure for labelling, fixation and extraction q[ cell cultures. Plastic Petri dishes
(35 x ~o ram.) containing an ~8 ram. 2 coverslip (Corning no. I) were seeded with LLC-MK2 cells. On the following day there were about 2 x ~o 5 cells on each coverslip. The growth medium from the plates containing the coverslips was removed and 2 ml. of medium with or without streptovitacin A (3oo/~g./ml.) was added to each plate. Six replicate cultures were used for each variable. Four hours after treatment the compound was removed from one group, the cells were washed three times with 2 ml. of phosphate buffered saline and covered with medium. At various times thereafter, the medium was removed from the dishes containing the coverslip and I ml. of [aH]leucine (2. 5 #c/ml.) was added to each plate for a 30 min. pulse. At the end of this interval, the medium was removed and the cells were fixed for ~o min. with cold acetic acid-ethanol (~ : 3)-The coverslips were then removed, placed in holders (Chen Type Staining Rack, A. H. Thomas Co.), and kept in 7 ° ~ ethanol. Cells were then treated with 0-5 Mperchloric acid for 3o min. at 37 °, washed with water and dehydrated by dipping the racks in alcohol ether (l : ~) followed by two dips in ether. After drying, the coverslip cultures were placed in counting vials containing lo ml. of scintillation fluid. The fluid contained 4 g. of 2,5-diphenyloxazole and 5 ° rag. of I, 4-bis-a-(5-phenyloxazolyl)-benzene dissolved in a litre of toluene. The radioactivity was determined with a PickerNuclear Liquimat 22o.
RESULTS

Effect of puromycin, cycloheximide and streptovitacin A on va:cinia virus multiplication and virus cytopathic effects
Cycloheximide (o'I25 #g./ml.) or streptovitacin A (0.o62 #g./ml.) was sufficient to inhibit the virus yield by 75 ~ (Fig. I) . The virus inhibitory activity of puromycin was much less. About zoo-to 4oo-fold more puromycin (24/zg./ml.) than cycloheximide or streptovitacin A was required to obtain the same inhibition of virus multiplication.
These inhibitors had a similar effect on virus-induced cell damage (Table ~) . Within 3 to 4 hr after infection, Ioo ~o of untreated cells showed virus cytopathic effects. Both cycloheximide and streptovitacin A, at a concentration of l/~g./ml., prevented about 70 %o of the cytopathic effects 3 hr after infection, while 83 #g./ml. of puromycin was required to inhibit cell damage to the same degree. Higher concentrations of cycloheximide (300 #g./ml.) or streptovitacin A (300 ffg./ml.), however, prevented virus cytopathic effects for only Io to I2 hr. Fourteen hours after infection 2o to 30 ~o of the treated cells showed the virus effects and at 24 hr cytopathic effects were pronounced. In contrast, puromycin-treated cultures (33o #g./ml.) showed very little cell damage 24 hr after infection and treatment. 
Vaccinia virus yields and cytopathic effects after removal of inhibitors of protein synthesis
Vaccinia virus yields in cultures treated with puromycin (33o #g./ml.) and cycloheximide (3oo #g./ml.) approximated the virus yields of untreated cultures when the antibiotics were removed 4 hr after infection (Table 2) . Cultures treated with strepto-vitacin A, however, yielded very much less virus at 24 hr even though the drug had been removed at 4 hr. In untreated cultures virus cytopathic effects were maximal by 3 hr and 45 min. (Fig. 2) . Shortly after the removal of puromycin (33o #g./ml.) and cycloheximide (300 #g./ml.) at 4 hr, virus cytopathic effects appeared and about [ hr later cell rounding was maximal in both cultures. In cultures treated with streptovitacin A, however, a curious 'cytopathic lag' was observed. Virus induced cell damage did not begin until ] hr after the removal of the compound and reached maximum after 3 hr. Virus÷ streptovitacin A 300 #g./ml. 6'5 × Io ~ 0"5 Virus + streptovitacin A 300/zg./ml. 
The rate of incorporation of L-leucine-4,5-'~H by LLC-MK2 cells in the presence or after the removal of streptovitacin A
Dales 0965) reported that L cells did not synthesize any protein up to 2 hr after the removal of streptovitacin A (~o #g./ml.).
When streptovitacin A (3oo #g./ml.) was removed from LLC-MK2 cells, 4 hr after treatment (Table 3) , the rate of incorporation of [~H]leucine did not change for t hr. Between 1.5 and 2.o hr after the removal of the drug, the rate of protein synthesis was o/ 3 ~ of control and from 2.o to 2"5 hr after removal protein synthesis was Iz/o of control. Vaccinia+puromycin 7"5 x io ~ 4"5 x Io 4 --(33o #g./ml.) Vaccinia+cycloheximide 8"5 × IO 6 4"8 X IO 4 --(3oo #g./ml.) Vaccinia+ streptovitacin A 9"8 × IO 6 --3"9 x Io ~ --(300 #g./ml.)
The 24 hr titre of vaccinia virus seed was ~.5 x Io 7 p.f.u./ml. 
The effect of protein inhibitors and adsorption and penetration of vaccinia virus
The inhibitors of protein synthesis used in this study did not affect adsorption and penetration of virus into LLC-MK2 cells (Table 4) . Virus cytopathic effects were maximal at the usual time after infection, i.e. 4 hr (see Group III, column 2), and to the same extent in all cultures except those treated with streptovitacin A. Antibody neutralization of all unadsorbed virus did not alter either the qualitative or the quantitative results, establishing that cytopathic effects were due to initial penetration of the virus at the first addition of virus and inhibitor and not to reinfection by unadsorbed virus after the protein inhibitors were removed. The efficacy of the virus neutralization achieved with antiserum was demonstrated by the small number of plaques in the neutralized supernatant (Group III, column I). New infectious virus was produced by all the treated-infected cultures when antibody-neutralized virus in the supernatant medium was washed away (4 hr after infection), indicating that tl-,e virus progeny was derived from input virus that penetrated during the initial infection when the inhibitors of protein synthesis were present.
The effect of treatment of LLC-MK2 cells for 4 hr with inhibitors of protein synthesis beJbre infection with vaccinia virus
It has been suggested that since puromycin causes the premature release of polypeptides from the synthetic site of the ribosomes, these ribosomes could become readily available for replication of Newcastle disease virus, thus effectively shortening its eclipse period (Wheelock, I962). Compound 05o/~g./ml.) 1-4 x I@ o'5 3"7 x Io 5 o3 Compound 050/zg./ml.) 9.2 x io n 3 t 7"9 x io ~ 0"7 removed 4 hr after infection Ccmpound (IO/zg./ml.) 1.5 x Io 5 0"5 3"9 x IO 5 0'4 Compound (to #g./ml.) 9"I x io 6 30 5"9 x io n 5"A removed 4 hr after infection * The I hr background value of virus was 6'9x IO 5 p.f.u./ml, for LLC-MK2 cells and l'l x Io 6 p.f.u./ml, for L2 cells.
To determine whether pre-treatment of cell cultures with protein inhibitors could shorten the eclipse period of vaccinia virus, LLC-MK2 cells were treated for 4hr with puromycin (33o/zg./ml.), cycloheximide (3oo#g./ml.) or streptovitacin A (3oo #g./ml.), then washed three times with warm phosphate buffered saline and infected with vaccinia virus at an added multiplicity of 5o. The yields of virus from both sets of pre-treated cultures were similar to the yields of untreated-infected cultures (Table 5) .
Removal of the compounds was followed by infection. The cytopathic effects appeared at about the same time as in untreated-infected controls, except in the cells treated for 4 hr with streptovitacin A where virus cytopathic effects were recognizable only after a delay of 2 hr. The ' cytopathic lag' in cultures treated with streptovitacin A was noted above (Fig. 2) .
Vaccinia virus yields after the removal of streptovitacin A from LLC-MK2 or L2 cells
Both cycloheximide and streptovitacin A readily enter into rabbit reticulocytes, but only cycloheximide diffuses out of these cells (Colombo, Felieetti & Baglioni, 1966) . Dales 0965) showed that L cells treated with streptovitacin A and infected with vaccinia virus did not produce infectious virus even though the compound was washed from the cells 2 hr after infection. Tarro (I967), on the other hand, showed that the removal of streptovitacin A (IO #g./ml.) from BS-C-I cells infected with poliovirus resulted in a reduction in the amount of infectious virus formed, but not in the suppression of virus synthesis. Since LLC-MK2 cells treated with streptovitacin A yielded submaximal amounts of virus (Table 2) , L 2 cells were compared with LLC-MK2 cells. When streptovitacin A (Io #g./ml. or I5o #g./ml.), was removed from vaccinia virus-infected L2 cells, 95 to 99 ~ of the infectious virus yield was inhibited, but under similar conditions only 70 ~ of the virus yield was inhibited in LLC-MK2 cells (Table 6 ). 
Vaccinia virus yieM and cytopathic effects in the presence or after the removal of puromycin aminonucleoside
Puromycin aminonucleoside inhibits RNA synthesis. It is known to inhibit preferentially ribosomal RNA rather than messenger RNA in L cells (Farnham & Dubin, I965) and in HeLa cells (Studzinski & Ellem, 1968) . Its effects on cell damage induced by vaccinia virus were therefore investigated. At a concentration of 33o #g./ml. it did not protect the majority of the LLC-MK2 cells from virus cytopathic effects 4 hr after infection (Table 7) . However, although cytopathic effects occurred, puromycin aminonucleoside (33o #g./ml.) reduced the virus yield by about 8o ~o when it was measured 24 hr after infection. The removal of the compound from cultures 4 hr after infection had no effect on the final virus yield, which was still reduced by about 8o ~ when measured at 24 hr after inSection.
DISCUSSION
The results with cycloheximide and streptovitacin A have provided additional evidence that the early cytopathic effects induced by vaccinia virus are related to protein synthesis. A comparison between the effect of puromycin and that of cycloheximide and streptovitacin A shows that both cycloheximide and streptovitacin A can prevent virus multiplication and early cytopathic effects at much lower concentrations than puromycin. This result could be explained by the fact that low concentrations of both cycloheximide (Wettstein, Noll & Penman, I964) and streptovitacin A (Dales, I965) are known to cause marked inhibition of protein synthesis. High concentrations of puromycin can prevent virus cytopathic effects up to 24 hr after infection and treatment, whereas high concentrations of both cycloheximide and streptovitacin A allow virus-induced cell damage to occur at this time. These results could be due to the fact that high concentrations of cycloheximide 0ooo #g./ml.) do not completely inhibit protein synthesis (Wettstein et al. I964; Siegel & Sisler, I963) . Thus, it is conceivable that a virus-induced protein could be slowly made and accumulate to cause the late appearing virus cytopathic effects in the presence of cycloheximide and streptovitacin A but not in the presence of puromycin.
The results from the drug-removal experiments indicate that the prevention of virus cytopathic effects by puromycin and cycloheximide can be readily reversed, whereas that of streptovitacin A cannot. This 'cytopathic lag' observed after the removal of streptovitacin A correlates with the finding that protein synthesis in LLC-MK2 cells does not resume for about 2 hr. These results also indicate that the early cytopathic effects induced by vaccinia virus result from the resumption of some cytoplasmic protein assembly. Studies on the chronological relationship of protein synthesis and cytopathic effects after the removal of puromycin and cycloheximide are in progress.
The results from the comparative study of virus yield in L 2 cells and LLC-MK 2 cells after the removal of streptovitacin A show that this compound behaves differently in these cell types. One possible explanation of this result could be that streptovitacin A diffuses out of the monkey kidney cells more readily than from L2 cells, thus allowing some virus to be made by the undamaged cells. In L2 cells, however, the drug might come out more slowly; thus most cells become damaged to the point where they can no longer produce any virus.
Finally, the results with the aminonucleoside of puromycin showed that this compound inhibited virus multiplication markedly but did not prevent major virus cytopathic effects 4 hr after infection. These results indicate that inhibition of RNA synthesis by this compound, especially that of the ribosomal RNA (Farnham & Dubin, t965; Studzinski & Ellem, I968) , without the inhibition of protein synthesis (Nathans & Neidle, t963; Farnham, I965) , is not sufficient to overcome the development of virus induced cytopathological effects. These results also indicate that puromycin does not change to its aminonucleoside inside the cells, because if it did we should have seen virus cytopathic effects in infected puromycin-treated cultures which, as shown earlier, do not occur.
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